GenVec to suspend TNFerade trials Gaithersburg-based GenVec has run into a problem with its top drug candidate, and investors have had an adverse reaction. GenVec says the US Food and Drug Administration has requested that clinical trials  

Which section of a newspaper would this article likely appear in? 